The steroid specificity of the estrogen-receptor of human breast carcinoma.
D000731:Androstanes / Q000494:pharmacology; D000737:Androstenols / Q000494:pharmacology; D001665:Binding Sites; D001940:Breast / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism*; D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology; D003600:Cytosol / Q000378:metabolism; D003687:Dehydroepiandrosterone / Q000494:pharmacology; D004958:Estradiol / Q000378:metabolism*; D004964:Estriol / Q000494:pharmacology; D004970:Estrone / Q000494:pharmacology; D005260:Female; D006027:Glycosides / Q000494:pharmacology; D006801:Humans; D006914:Hydroxysteroids / Q000494:pharmacology; D008408:Mastectomy; D009277:Nandrolone / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000187:drug effects; D013329:Structure-Activity Relationship; D014316:Tritium
D000731:Androstanes; D000737:Androstenols; D006027:Glycosides; D006914:Hydroxysteroids; D011956:Receptors, Cell Surface; D014316:Tritium; D004970:Estrone; D003687:Dehydroepiandrosterone; D011374:Progesterone; D004958:Estradiol; D009277:Nandrolone; D004964:Estriol